We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$87.3B
AUM Growth
+$1.98B
Cap. Flow
-$6.58B
Cap. Flow %
-7.53%
Top 10 Hldgs %
16.66%
Holding
8,883
New
1,058
Increased
3,196
Reduced
3,486
Closed
936

Top Sells

Rank Stock Value
1
HSH
HILLSHIRE BRANDS CO
HSH
+$224M
2
VZ icon
Verizon
VZ
+$191M
3
MET icon
MetLife
MET
+$189M
4
LSI
LSI CORPORATION
LSI
+$189M
5
WFC icon
Wells Fargo
WFC
+$182M

Sector Composition

Rank Sector Weight
1 Financials 8.09%
2 Consumer Discretionary 7.64%
3 Energy 7.19%
4 Industrials 5.71%
5 Technology 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUR icon
7501
PUT
Pluri
PLUR
$16.8M
$9K ﹤0.01%
+38
New +$10.5K
PLX icon
7502
CALL
Protalix BioTherapeutics
PLX
$183M
$9K ﹤0.01%
240
+50
+26% +$2.02K
PZG icon
7503
Paramount Gold Nevada
PZG
$99.5M
$9K ﹤0.01%
9,072
+1,095
+14% +$1.13K
SITC icon
7504
PUT
SITE Centers
SITC
$227M
$9K ﹤0.01%
388
-155
-29% -$3.43K
WRB icon
7505
PUT
W.R. Berkley
WRB
$27.2B
$9K ﹤0.01%
675
-1,013
-60% -$13.2K
TEN
7506
PUT
Tsakos Energy Navigation Ltd
TEN
$1.2B
$9K ﹤0.01%
260
-1,120
-81% -$40.4K
FRGI
7507
PUT
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$9K ﹤0.01%
200
-5,900
-97% -$238K
LMNX
7508
PUT
DELISTED
Luminex Corp
LMNX
$9K ﹤0.01%
+500
New +$8.8K
CLGX
7509
PUT
DELISTED
Corelogic, Inc.
CLGX
$9K ﹤0.01%
300
-5,400
-95% -$156K
CUB
7510
PUT
DELISTED
Cubic Corporation
CUB
$9K ﹤0.01%
200
-1,600
-89% -$76.4K
CCMP
7511
PUT
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$9K ﹤0.01%
200
-600
-75% -$26K
INTX
7512
CALL
DELISTED
Intersections, Inc.
INTX
$9K ﹤0.01%
+1,900
New +$9.48K
ANTH
7513
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$9K ﹤0.01%
+350
New +$8.64K
RATE
7514
PUT
DELISTED
Bankrate Inc
RATE
$9K ﹤0.01%
500
-1,000
-67% -$16.4K
WINT
7515
DELISTED
Windtree Therapeutics Inc
WINT
$9K ﹤0.01%
370
-1,277
-78% -$32.6K
FST
7516
DELISTED
FOREST OIL CORPORATION
FST
$9K ﹤0.01%
4,163
-1,296,415
-100% -$2.76M
END
7517
PUT
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
$9K ﹤0.01%
6,900
-3,200
-32% -$7.43K
AIM
7518
AIM ImmunoTech
AIM
$6.52M
$9K ﹤0.01%
1
-4
-80% -$71.6K
ALB icon
7519
Albemarle
ALB
$13.9B
$8K ﹤0.01%
109
-113,171
-100% -$7.76M
CORT icon
7520
CALL
Corcept Therapeutics
CORT
$12.8B
$8K ﹤0.01%
3,000
+2,600
+650% +$7.67K
CPRX
7521
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$8K ﹤0.01%
3,200
+800
+33% +$1.71K
EVC icon
7522
PUT
Entravision Communication
EVC
$1.07B
$8K ﹤0.01%
1,300
+1,000
+333% +$5.56K
FBIO icon
7523
CALL
Fortress Biotech
FBIO
$109M
$8K ﹤0.01%
320
-153
-32% -$4.03K
FORM icon
7524
PUT
FormFactor
FORM
$8.21B
$8K ﹤0.01%
1,000
-1,000
-50% -$6.64K
HLIO icon
7525
PUT
Helios Technologies
HLIO
$2.57B
$8K ﹤0.01%
+200
New +$7.94K

Similar funds

Citadel Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Citadel Advisors held 8,883 positions worth $87.3B, up 2.3% from $85.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors withdrew a net $6.58B in Q2 2014, closing 936 positions and reducing 3,486 holdings. Its most notable exit was LSI CORPORATION, an estimated $189M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.1% of assets, down from 8.8% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Citadel Advisors opened a new position in MEMORIAL RESOURCE DEV CORP COM STK (DE) worth $109M.

  • Citadel Advisors's largest Q2 2014 buy was MEMORIAL RESOURCE DEV CORP COM STK (DE): 4,494,314 shares worth $109M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $689M increase.
  • Citadel Advisors's biggest Q2 2014 reduction was HILLSHIRE BRANDS CO, cutting an estimated $224M.
  • Citadel Advisors fully exited LSI CORPORATION in Q2 2014, selling an estimated $189M.
  • Citadel Advisors's ten largest holdings make up 17% of its $87.3B portfolio in Q2 2014.
  • Citadel Advisors opened 1,058 new positions and closed 936 in Q2 2014.
  • Citadel Advisors's portfolio value rose 2.3% quarter-over-quarter to $87.3B.

Based on Citadel Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.